vs

Side-by-side financial comparison of Align Technology (ALGN) and Ingredion Inc (INGR). Click either name above to swap in a different company.

Ingredion Inc is the larger business by last-quarter revenue ($1.8B vs $1.0B, roughly 1.7× Align Technology). Align Technology runs the higher net margin — 10.8% vs 9.5%, a 1.3% gap on every dollar of revenue. On growth, Align Technology posted the faster year-over-year revenue change (6.2% vs -2.4%). Over the past eight quarters, Align Technology's revenue compounded faster (0.6% CAGR vs -3.4%).

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandib...

Ingredion Inc. is an American food and beverage ingredient provider based in Westchester, Illinois, producing mainly starches, non-GMO sweeteners, stevia, and pea protein. The company turns corn, tapioca, potatoes, plant-based stevia, grains, fruits, gums and other vegetables into ingredients for the food, beverage, brewing, and pharmaceutical industries and numerous industrial sectors. It has about 12,000 employees in 44 locations, and customers in excess of 120 countries.

ALGN vs INGR — Head-to-Head

Bigger by revenue
INGR
INGR
1.7× larger
INGR
$1.8B
$1.0B
ALGN
Growing faster (revenue YoY)
ALGN
ALGN
+8.6% gap
ALGN
6.2%
-2.4%
INGR
Higher net margin
ALGN
ALGN
1.3% more per $
ALGN
10.8%
9.5%
INGR
Faster 2-yr revenue CAGR
ALGN
ALGN
Annualised
ALGN
0.6%
-3.4%
INGR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ALGN
ALGN
INGR
INGR
Revenue
$1.0B
$1.8B
Net Profit
$112.8M
$167.0M
Gross Margin
70.8%
24.5%
Operating Margin
13.6%
12.5%
Net Margin
10.8%
9.5%
Revenue YoY
6.2%
-2.4%
Net Profit YoY
21.0%
72.2%
EPS (diluted)
$1.57
$2.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALGN
ALGN
INGR
INGR
Q1 26
$1.0B
Q4 25
$1.0B
$1.8B
Q3 25
$995.7M
$1.8B
Q2 25
$1.0B
$1.8B
Q1 25
$979.3M
$1.8B
Q4 24
$995.2M
$1.8B
Q3 24
$977.9M
$1.9B
Q2 24
$1.0B
$1.9B
Net Profit
ALGN
ALGN
INGR
INGR
Q1 26
$112.8M
Q4 25
$135.8M
$167.0M
Q3 25
$56.8M
$171.0M
Q2 25
$124.6M
$196.0M
Q1 25
$93.2M
$197.0M
Q4 24
$103.8M
$97.0M
Q3 24
$116.0M
$188.0M
Q2 24
$96.6M
$148.0M
Gross Margin
ALGN
ALGN
INGR
INGR
Q1 26
70.8%
Q4 25
65.3%
24.5%
Q3 25
64.2%
25.1%
Q2 25
69.9%
26.0%
Q1 25
69.5%
25.7%
Q4 24
70.0%
24.9%
Q3 24
69.7%
25.6%
Q2 24
70.3%
23.7%
Operating Margin
ALGN
ALGN
INGR
INGR
Q1 26
13.6%
Q4 25
14.8%
12.5%
Q3 25
9.7%
13.7%
Q2 25
16.1%
14.8%
Q1 25
13.4%
15.2%
Q4 24
14.5%
9.0%
Q3 24
16.6%
14.3%
Q2 24
14.3%
12.8%
Net Margin
ALGN
ALGN
INGR
INGR
Q1 26
10.8%
Q4 25
13.0%
9.5%
Q3 25
5.7%
9.4%
Q2 25
12.3%
10.7%
Q1 25
9.5%
10.9%
Q4 24
10.4%
5.4%
Q3 24
11.9%
10.1%
Q2 24
9.4%
7.9%
EPS (diluted)
ALGN
ALGN
INGR
INGR
Q1 26
$1.57
Q4 25
$1.88
$2.58
Q3 25
$0.78
$2.61
Q2 25
$1.72
$2.99
Q1 25
$1.27
$3.00
Q4 24
$1.40
$1.43
Q3 24
$1.55
$2.83
Q2 24
$1.28
$2.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALGN
ALGN
INGR
INGR
Cash + ST InvestmentsLiquidity on hand
$1.1B
$1.0B
Total DebtLower is stronger
Stockholders' EquityBook value
$4.1B
$4.3B
Total Assets
$6.3B
$7.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALGN
ALGN
INGR
INGR
Q1 26
$1.1B
Q4 25
$1.1B
$1.0B
Q3 25
$1.0B
$915.0M
Q2 25
$901.2M
$861.0M
Q1 25
$873.0M
$837.0M
Q4 24
$1.0B
$997.0M
Q3 24
$1.0B
$877.0M
Q2 24
$761.4M
$505.0M
Stockholders' Equity
ALGN
ALGN
INGR
INGR
Q1 26
$4.1B
Q4 25
$4.0B
$4.3B
Q3 25
$4.0B
$4.2B
Q2 25
$3.9B
$4.2B
Q1 25
$3.8B
$4.0B
Q4 24
$3.9B
$3.8B
Q3 24
$3.9B
$4.0B
Q2 24
$3.8B
$3.7B
Total Assets
ALGN
ALGN
INGR
INGR
Q1 26
$6.3B
Q4 25
$6.2B
$7.9B
Q3 25
$6.2B
$7.8B
Q2 25
$6.2B
$7.8B
Q1 25
$6.1B
$7.5B
Q4 24
$6.2B
$7.4B
Q3 24
$6.4B
$7.5B
Q2 24
$6.2B
$7.2B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALGN
ALGN
INGR
INGR
Operating Cash FlowLast quarter
$151.0M
$405.0M
Free Cash FlowOCF − Capex
$270.0M
FCF MarginFCF / Revenue
15.4%
Capex IntensityCapex / Revenue
7.7%
Cash ConversionOCF / Net Profit
1.34×
2.43×
TTM Free Cash FlowTrailing 4 quarters
$511.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALGN
ALGN
INGR
INGR
Q1 26
$151.0M
Q4 25
$223.2M
$405.0M
Q3 25
$188.7M
$277.0M
Q2 25
$128.7M
$185.0M
Q1 25
$52.7M
$77.0M
Q4 24
$286.1M
$436.0M
Q3 24
$263.7M
$479.0M
Q2 24
$159.8M
$312.0M
Free Cash Flow
ALGN
ALGN
INGR
INGR
Q1 26
Q4 25
$187.3M
$270.0M
Q3 25
$169.0M
$172.0M
Q2 25
$107.2M
$84.0M
Q1 25
$27.4M
$-15.0M
Q4 24
$263.1M
$311.0M
Q3 24
$233.9M
$429.0M
Q2 24
$106.4M
$257.0M
FCF Margin
ALGN
ALGN
INGR
INGR
Q1 26
Q4 25
17.9%
15.4%
Q3 25
17.0%
9.5%
Q2 25
10.6%
4.6%
Q1 25
2.8%
-0.8%
Q4 24
26.4%
17.3%
Q3 24
23.9%
22.9%
Q2 24
10.3%
13.7%
Capex Intensity
ALGN
ALGN
INGR
INGR
Q1 26
Q4 25
3.4%
7.7%
Q3 25
2.0%
5.8%
Q2 25
2.1%
5.5%
Q1 25
2.6%
5.1%
Q4 24
2.3%
6.9%
Q3 24
3.0%
2.7%
Q2 24
5.2%
2.9%
Cash Conversion
ALGN
ALGN
INGR
INGR
Q1 26
1.34×
Q4 25
1.64×
2.43×
Q3 25
3.33×
1.62×
Q2 25
1.03×
0.94×
Q1 25
0.57×
0.39×
Q4 24
2.76×
4.49×
Q3 24
2.27×
2.55×
Q2 24
1.66×
2.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ALGN
ALGN

Clear Aligner$856.0M82%
CAM Services$184.1M18%

INGR
INGR

Food And Industrial Ingredients LATAM Segment$599.0M34%
Texture And Healthful Solutions Segment$598.0M34%
Food And Industrial Ingredients U.S.Canada Segment$486.0M28%
Other$74.0M4%

Related Comparisons